|
| |
Bladder Control Problem
Overview
In people with an overactive bladder (OAB), the layered, smooth muscle that
surrounds the bladder (detrusor muscle) contracts spastically, sometimes without
a known cause, which results in sustained, high bladder pressure and the urgent
need to urinate (called urgency). Normally, the detrusor muscle contracts and
relaxes in response to the volume of urine in the bladder and the initiation of
urination.
People with OAB often experience urgency at inconvenient and unpredictable times
and sometimes lose control before reaching a toilet. Thus, overactive bladder
interferes with work, daily routine, intimacy and sexual function; causes
embarrassment; and can diminish self-esteem and quality of life.
Urination
Urination (micturition) involves processes within the urinary tract and the
brain. The slight need to urinate is sensed when urine volume reaches about
one-half of the bladder's capacity. The brain suppresses this need until a
person initiates urination.
Once urination has been initiated, the nervous system signals the detrusor
muscle to contract into a funnel shape and expel urine. Pressure in the bladder
increases and the detrusor muscle remains contracted until the bladder empties.
Once empty, pressure falls and the bladder relaxes and resumes its normal shape.
Incidence and Prevalence
Overactive bladder affects men and women equally. The U.S. Department of Health
and Human Services has reported that approximately 13 million people in the
United States suffer from OAB and other forms of incontinence.
Causes
A malfunctioning detrusor muscle causes overactive bladder. Identifiable
underlying causes include the following:
Nerve damage caused by abdominal trauma, pelvic trauma, or
surgery
Bladder stones
Drug side effects
Neurological disease (e.g., multiple sclerosis, Parkinson's disease, stroke,
spinal cord lesions)
Other conditions can produce symptoms similar to those
experienced with overactive bladder, the most common of which is urinary tract
infection (UTI) in women.
Signs and Symptoms
Three symptoms are associated with an overactive bladder:
Frequency (frequent urination)
Urgency (urgent need to urinate)
Urge incontinence (strong need to urinate followed by leaking or involuntary
and complete voiding)
Back to Top
Diagnosis
A complete medical history, including a voiding diary; a physical examination;
and one or more diagnostic procedures help the physician determine an
appropriate treatment plan for overactive bladder.
Medical history
The medical history includes information about bowel habits, patterns of
urination and leakage (when, how often, how severe), and whether there is pain,
discomfort, or straining when voiding. The patient's history of illnesses,
pelvic surgeries, pregnancies, and medications currently used also supply the
physician with information relevant to making a diagnosis. In the elderly, a
mental status evaluation and assessment of social and environmental factors may
be performed.
Physical examination
A physical examination includes a neurologic status evaluation and examination
of the abdomen, rectum, genitals, and pelvis. The cough stress test, in which
the patient coughs forcefully while the physician observes the urethra, allows
observation of urine loss. Instantaneous leakage with coughing indicates a
diagnosis of stress incontinence. Leakage that is delayed or persistent after
the cough indicates urge incontinence.
The physical examination also helps the physician identify medical conditions
that may be the cause of overactive bladder. For instance, poor reflexes or
sensory responses may indicate a neurological disorder.
Urinalysis
Examination of the urine may identify medical conditions associated with
overactive bladder, such as the following:
Bacteriuria—presence of bacteria in urine; indicates
infection
Glycosuria—excess glucose in urine; may indicate diabetes
Hematuria—blood in urine; may indicate kidney disease
Proteinuria—excess protein in urine; may indicate kidney disease, cardiac
disease, blood disease
Pyuria—presence of pus in urine; indicates infection
Specialized Testing
If overactive bladder persists after diagnosis and treatment, additional testing
may be needed. Urologists perform urodynamic, endoscopic, and imaging tests to
obtain a more extensive evaluation of the lower urinary tract to determine a new
treatment plan.
Postvoid residual volume (PRV)
This procedure requires catheterization or pelvic ultrasound. The patient voids
just before the PRV is measured. This initial void should be observed for
hesitancy, straining, or interrupted flow. A PRV less than 50 mL indicates
adequate bladder emptying. Repeated measurements of 100 to 200 mL or higher
represent inadequate bladder emptying. The clinical setting and the patient's
readiness to void may affect the test result; therefore, repeated measurements
may be necessary.
Urodynamic Testing
Cystometry may be used to measure the anatomic and functional status of the
bladder and urethra. The cystometer is an instrument that measures the pressure
and capacity of the bladder; thus evaluating the function of the detrusor
muscle. Simple cystometry detects abnormal detrusor compliance, but abdominal
pressure is not included and the results must be evaluated with caution.
The multichannel, or subtracted, cystometrogram simultaneously measures
intra-abdominal, total bladder, and true detrusor pressures. This allows
involuntary detrusor contractions to be distinguished from increased
intra-abdominal pressure. The voiding cystometrogram detects outlet obstruction
in patients who are able to void.
Uroflowmetry identifies abnormal voiding patterns. Urethral pressure
profilometry measures the resting and dynamic pressures in the urethra.
Endoscopic Tests
Cystoscopy may be performed when urodynamic testing fails to duplicate symptoms,
when the patient experiences new symptoms (e.g., cystitis, pain), or when
urinalysis reveals a disease process (e.g., menaturia, pyuria). Cystoscopy
identifies the presence of bladder lesions (e.g., cysts) and foreign bodies.
Imaging Tests
X-rays and ultrasound may be used to evaluate anatomic conditions associated
with overactive bladder. Imaging of the lower urinary tract before, during, and
after voiding is helpful in examining the anatomy of the urinary bladder and
urethra
Treatment
Treatment may include one or more of the following:
Bladder retraining
Medication
Oxybutynin transdermal system
Sacral nerve stimulation
Surgery
Bladder Training with Timed Voiding
This treatment is used for urge and overflow incontinence. The patient keeps a
voiding diary of all episodes of urination and leaking, and the physician
analyzes the chart and identifies the pattern of urination. The patient uses
this timetable to plan when to empty the bladder to avoid accidental leakage. In
bladder training, biofeedback and Kegel exercise help the patient resist the
sensation of urgency, postpone urination, and urinate according to the
timetable.
Medication
Drugs such as oxybutynin chloride (Ditropan XL®) and tolterodine (Detrusitol®,
Detrol LA®) are taken orally, once a day, for overactive bladder. These
medications are antimuscarinics, which affect the central nervous system and
muscarinic receptors in smooth muscle. They relax the smooth muscle of the
bladder, reducing detrusor contraction and subsequent wetting accidents, usually
within 2 weeks. Newer drugs indicated for OAB include trospium chloride (Sanctura™),
derifenacin (Enablex®), and solifenacin (Vesicare®).
Side effects, including dry mouth, constipation, headache, blurred vision, dry
eyes, hypertension, drowsiness, and urinary retention occur in approximately 50%
of those who use these medications. They should be used with caution in patients
with narrow-angle glaucoma or certain types of kidney, liver, stomach, and
urinary problems. Women who are pregnant should not take these medications
without consulting a physician.
Side effects, including dry mouth, constipation, headache, blurred vision,
hypertension, drowsiness, and urinary retention occur in approximately 50% of
those who use the drugs. People with glaucoma or certain types of kidney, liver,
stomach, and urinary problems are advised not to take Ditropan XL. Although
there is no evidence that Ditropan XL causes birth defects, pregnant women
should not take it without consulting a physician.
Oxybutynin Transdermal System
The oxybutynin transdermal system (Oxytrol™) is a thin, flexible, clear patch
that is applied to the skin of the abdomen or hip, twice weekly, to treat
overactive bladder. This treatment delivers oxybutynin continuously through the
skin into the bloodstream and relieves symptoms for up to 4 days allowing twice
a week dosing.
Patients who have urinary or gastric retention, uncontrolled narrow-angle
glaucoma, and those with hypersensitivity to oxybutynin should not use the
oxybutynin transdermal system.
Side effects are usually mild and include adverse reactions at the site of
application, dry mouth, and constipation.
Sacral Nerve Stimulation
InterStim® therapy is a reversible treatment for people with urge incontinence
caused by overactive bladder who do not respond to behavioral treatments or
medication. InterStim is an implanted neurostimulation system that sends mild
electrical pulses to the sacral nerve, the nerve near the tailbone that
influences bladder control muscles. Stimulation of this nerve may relieve the
symptoms related to urge incontinence.
Prior to implantation, the effectiveness of the therapy is tested on an
outpatient basis with an external InterStim device. For a period of 3 to 5 days,
the patient records voiding patterns that occur with stimulation. The record is
compared to recorded voiding patterns without stimulation. The comparison
demonstrates whether the device effectively reduces symptoms. If the test is
successful, the patient may choose to have the device implanted.
The procedure requires general anesthesia. A lead (a special wire with
electrical contacts) is placed near the sacral nerve and is passed under the
skin to a neurostimulator, which is about the size of a stopwatch. The
neurostimulator is placed under the skin in the upper buttock.
Adjustments can be made at the doctor’s office with a programming device that
sends a radio signal through the skin to the neurostimulator. Another
programming device is given to the patient to further adjust the level of
stimulation, if necessary. The system can be turned off at any time.
Possible adverse effects include the following:
Change in bowel function
Infection
Lead movement
Pain at implant sites
Unpleasant stimulation or sensation
Surgery
Surgical augmentation of the bladder is reserved for people who do not benefit
from bladder retraining or medication.
Those who cannot take medication due to medical conditions or intolerance may
find incontinence management devices helpful.
Elimination and Challenge Diet
Bladder control problems that are not the result of neurological damage, poor muscle tone, or hormone deficiencies may result from irritability within the bladder or urethral tissues caused by chronic inflammation and/or food sensitivities. An elimination and challenge diet can help determine a food sensitivity. Symptoms that can occur on a food challenge include the following:
Headache (may be brief or prolonged)
Nausea, stomachache, sharp abdominal pain
Sore throat, stuffy nose, runny nose, itchy nose or eyes
Skin rash or itching, facial flushing, red ears
Sleepiness, insomnia, fatigue, apathy
Irritability, depression, anxiety
Excitability (feeling hyper or "buzzed")
Aching or twitching muscles
Symptoms associated with food challenges may not be the same symptoms experienced before the elimination process. For example, before the elimination and challenge diet began, a patient's symptom was chronic sinus pain, but a stomachache occurred during the challenge. This does not mean that the food group being challenged was not causing the sinus pain. It is just that the body and immune system react differently when the offending agent is removed and then reintroduced.
Option 1
For 2 to 6 weeks, eliminate all suspect foods and focus diet on fresh fruits, vegetables, potatoes, yams, animal protein (fish, poultry, lamb), and nonglutenous grains (rice, buckwheat). Eat organic foods whenever possible.
After 2 to 6 weeks of maintaining a strict elimination diet, there should be relief from symptoms. Weight may also be lost. Now begin the challenge. Start with the food group that is least problematic. Challenge a specific food group for one day only. Eat several servings of that food group throughout the day. Then do not eat that food again for at least 48 hours while continuing to eat only elimination diet foods. If symptoms do not return after 48 hours, go on to the next suspected food group. However, feel free to wait more than 48 hours. Waiting a week between food group challenges is optimal. This increases the accuracy of the diagnosis. Remember to challenge only one food group at a time.
Continue this process until the problematic food group is determined. In most cases, reactions occur within 48 hours. Rarely do symptoms appear several days or weeks later.
Option 2
Maintain a regular diet and eliminate only the food group that is believed to be causing the symptoms. Eliminate all items in that food group for at least 1 month. If the symptoms disappear before the end of the month, continue to abstain from that food group for another week before starting the challenge.
To do the challenge, eat several servings of the suspect food group during a 24-hour period. Then return to the elimination diet and do not eat the suspect food group for at least 48 hours. More often than not, immediate reactions occur if there is a sensitivity.
Herbal Support
Soothing urinary tract tonics may help heal the bladder and
related nervous irritation. Also drink 2 - 3 quarts of water daily.
Herbs to use as tea:
Cleavers (Galium aparine) - traditional urinary tonic
Marshmallow root (Althea officinalis) - soothing demulcent properties, best in "cold infusion" (Soak herb in cold water several hours; strain and drink.)
Buchu - soothing diuretic and antiseptic for the urinary system
Corn silk (Zea mays) - soothing, diuretic
Horsetail (Equisetum arvense) - astringent, tissue-healing properties, mild diuretic
Usnea lichen - very soothing and antiseptic
Anti-inflammatory Support
Flax oil: 1 tablespoon daily
Vitamin C: 500 mg, 2 to 3 times daily with meals
Bromelain 400 mg or Wobenzyme 5 tablets: 3 times a day away from meals
Vitamin E: 400 IU daily
Homeopathic Support
A trained homeopathic practitioner is needed to diagnose and prescribe a deep acting, constitutional remedy. For acute, symptomatic relief, the following remedies may relieve some of the symptoms associated with incontinence.
Causticum for stress incontinence associated with frequent
urging and difficulty urinating.
Natrum muriaticum for stress incontinence associated with the menopausal
symptoms of vaginal dryness, painful intercourse and a history of emotional
grief.
Pareira for difficulty urinating due to prostate enlargement.
Sepia for stress incontinence with sudden urging, especially associated with
vaginitis or prolapsed uterus.
Zincum for difficulty urinating while standing up (must sit to initiate flow),
associated with prostate problems.
Standard dosage for acute symptom relief is 12c to 30c, 3 to
5 pellets taken 3 times a day until symptoms resolve. If you have chosen the
right remedy, you should experience improvement shortly after the first or
second dose.
Warning: Most homeopathic remedies are delivered in a small pellet form that has
a lactose sugar base. If you are lactose intolerant, be advised that a
homeopathic liquid may be a better choice.
The above opinionated views and information serves to educated and informed consumer . The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. .It should not replaced professional advise and consultation.A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions
Copyright © 2004
Irene Nursing Home Pte Ltd
|